KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Change in Inventory (2016 - 2025)

Historic Change in Inventory for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to -$886000.0.

  • NovoCure's Change in Inventory rose 5324.54% to -$886000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $249000.0, marking a year-over-year decrease of 8378.91%. This contributed to the annual value of -$2.6 million for FY2024, which is 12879.25% down from last year.
  • NovoCure's Change in Inventory amounted to -$886000.0 in Q3 2025, which was up 5324.54% from $629000.0 recorded in Q2 2025.
  • In the past 5 years, NovoCure's Change in Inventory registered a high of $4.8 million during Q1 2022, and its lowest value of -$3.8 million during Q3 2021.
  • Moreover, its 5-year median value for Change in Inventory was $669000.0 (2023), whereas its average is $626000.0.
  • Per our database at Business Quant, NovoCure's Change in Inventory crashed by 704181.82% in 2021 and then surged by 59473.68% in 2023.
  • Over the past 5 years, NovoCure's Change in Inventory (Quarter) stood at $1.7 million in 2021, then surged by 34.02% to $2.3 million in 2022, then plummeted by 70.67% to $669000.0 in 2023, then crashed by 613.45% to -$3.4 million in 2024, then soared by 74.21% to -$886000.0 in 2025.
  • Its last three reported values are -$886000.0 in Q3 2025, $629000.0 for Q2 2025, and $3.9 million during Q1 2025.